Prevention of social stress-escalated cocaine self-administration by CRF-R1 antagonist in the rat VTA

Psychopharmacology

Volumn 218, Issue 1, 2011, Pages 257-269

  Boyson, Christopher O ^a   Miguel, Tarciso T ^b   Quadros, Isabel M ^c   DeBold, Joseph F ^a   Miczek, Klaus A ^a  

^a TUFTS UNIVERSITY   (United States)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

CP 154 526; CRF R1; Escalated cocaine self administration; Locomotor sensitization; Stress; VTA

Indexed keywords

BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; COCAINE; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1 ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG MISUSE; DRUG SELF ADMINISTRATION; DRUG SENSITIZATION; FEMALE; LOCOMOTION; LONG EVANS RAT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; SOCIAL STRESS; VENTRAL TEGMENTUM;

ANIMALS; COCAINE; COCAINE-RELATED DISORDERS; LOCOMOTION; MALE; NEURONS; PYRIMIDINES; PYRROLES; RATS; RATS, LONG-EVANS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; REINFORCEMENT SCHEDULE; SELF ADMINISTRATION; STRESS, PSYCHOLOGICAL; VENTRAL TEGMENTAL AREA;

EID: 82955235600     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2266-8     Document Type: Article

References (68)

1. Abercrombie ED, Keefe KA, DiFrischia DS, Zigmond MJ (1989) Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J Neurochem 52:1655-1658 (Pubitemid 19109526)
2. Bhatnagar S, Vining C (2003) Facilitation of hypothalamic-pituitary- adrenal responses to novel stress following repeated social stress using the resident/intruder paradigm. Horm Behav 43:158-165 (Pubitemid 36293286)
3. Björkqvist K (2001) Social defeat as a stressor in humans. Physiol Behav 73:435-442 (Pubitemid 32595719)
4. Brady KT, Dansky BS, Sonne SC, Saladin ME (1998) Posttraumatic stress disorder and cocaine dependence. Order of onset. Am J Addict 7:128-135 (Pubitemid 28228685)
5. Brown ZJ, Tribe E, D'souza NA, Erb S (2009) Interaction between noradrenaline and corticotrophin-releasing factor in the reinstatement of cocaine seeking in the rat. Psychopharmacology (Berl) 203:121-130
6. Cador M, Bjijou Y, Stinus L (1995) Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. Neuroscience 65:385-395
7. Capriles N, Rodaros D, Sorge RE, Stewart J (2003) A role for the prefrontal cortex in stress-and cocaine-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) 168:66-74 (Pubitemid 36851164)
8. Covington HE III, Miczek KA (2001) Repeated social-defeat stress, cocaine or morphine. Effects on behavioral sensitization and intravenous cocaine self-administration "binges". Psychopharmacology (Berl) 158:388-398 (Pubitemid 33141315)
9. Covington HE III, Kikusui T, Goodhue J, Nikulina EM, Hammer RP Jr, Miczek KA (2005) Brief social defeat stress: Long lasting effects on cocaine taking during a binge and zif268 mRNA expression in the amygdala and prefrontal cortex. Neuropsychopharmacology 30:310-321 (Pubitemid 40129482)
10. Covington HE III, Tropea TF, Rajadhyaksha AM, Kosofsky BE, Miczek KA (2008) NMDA receptors in the rat VTA: A critical site for social stress to intensify cocaine taking. Psychopharmacology (Berl) 197:203-216
11. Dunn AJ, Berridge CW (1990) Physiological and behavioral responses to corticotropin-releasing factor administration-is CRF a mediator of anxiety or stress responses? Brain Res Rev 15:71-100
12. Erb S, Shaham Y, Stewart J (1998) The role of corticotropin-releasing factor and corticosterone in stress-and cocaine-induced relapse to cocaine seeking in rats. J Neurosci 18:5529-5536 (Pubitemid 28311967)
13. Erb S, Petrovic A, Yi D, Kayyali H (2006) Central injections of CRF reinstate cocaine seeking in rats after postinjection delays of up to 3 h: An influence of time and environmental context. Psychopharmacology (Berl) 187:112-120 (Pubitemid 43876923)
14. Goeders NE (2002) The HPA axis and cocaine reinforcement. Psychoneuroendocrinology 27:13-33 (Pubitemid 34028156)
15. Goeders NE, Guerin GF (2000) Effects of the CRH receptor antagonist CP-154,526 on intravenous cocaine selfadministration in rats. Neuropsychopharmacology 23:577-586
16. Gray TS (1993) Amygdaloid CRF pathways. Role in autonomic, neuroendocrine, and behavioral responses to stress. Ann NY Acad Sci 697:53-60 (Pubitemid 24028954)
17. Higelin J, Py-Lang G, Paternoster C, Ellis GJ, Patel A, Dautzenberg FM (2001) 125I-Antisauvagine-30: A novel and specific highaffinity radioligand for the characterization of corticotropinreleasing factor type 2 receptors. Neuropharmacology 40:114-122 (Pubitemid 33779806)
18. Iwasaki-Sekino A, Mano-Otagiri A, Ohata H, Yamauchi N, Shibasaki T (2009) Gender differences in corticotropin and corticosterone secretion and corticotropin-releasing factor mRNA expression in the paraventricular nucleus of the hypothalamus and the central nucleus of the amygdala in response to footshock stress or psychological stress in rats. Psychoneuroendocrinology 34:226-237
19. Kalivas PW, Duffy P (1995) Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress. Brain Res 675:325-328
20. Kalivas PW, Duffy P, Latimer LG (1987) Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat. J Pharmacol Exp Ther 242:757-763 (Pubitemid 17156511)
21. Le AD, Harding S, Juzytsch W, Watchus J, Shalev U, Shaham Y (2000) The role of corticotropin-releasing factor instress-induced relapse to alcohol-seeking behavior in rats. Psychopharmacology (Berl) 150:317-324 (Pubitemid 30447852)
22. Lewis DA, Foote SL, Cha CI (1989) Corticotropin-releasing factor immunoreactivity in monkey neocortex: An immunohistochemical analysis. J Comp Neurol 290:599-613 (Pubitemid 20023017)
23. Liu X, Weiss F (2002) Additive effect of stress and drug cues on reinstatement of ethanol seeking: Exacerbation by history of dependence and role of concurrent activation of corticotropinreleasing factor and opioid mechanisms. J Neurosci 22:7856-7861 (Pubitemid 35379090)
24. Lodge DJ, Grace AA (2005) Acute and chronic corticotropin-releasing factor 1 receptor blockade inhibits cocaine-induced dopamine release: Correlation with dopamine neuron activity. J Pharmacol Exp Ther 314:201-206 (Pubitemid 41058256)
25. Makino S, Hashimoto K, Gold PW (2002) Multiple feedback mechanisms activating corticotropin-releasing hormone system in the brain during stress. Pharmacol Biochem Behav 73:147-158 (Pubitemid 34667027)
26. Mansbach RS, Brooks EN, Chen YL (1997) Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist. Eur J Pharmacol 323:21-26 (Pubitemid 27136433)
27. Marinelli M, Piazza PV (2002) Interaction between glucocorticoid hormones, stress and psychostimulant drugs. Eur J Neurosci 16:387-394 (Pubitemid 35471854)
28. McFarland K, Davidge SB, Lapish CC, Kalivas PW (2004) Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior. J Neurosci 24:1551-1560 (Pubitemid 38240949)
29. Miczek KA (1979) A new test for aggression in rats without aversive stimulation: Differential effects of d-amphetamine and cocaine. Psychopharmacology (Berl) 60:253-259 (Pubitemid 9147474)
30. Miczek KA, Mutschler NH (1996) Activational effects of social stress on IV cocaine self-administration in rats. Psychopharmacology (Berl) 128:256-264 (Pubitemid 26403121)
31. Miczek KA, Yap JJ, Covington HE III (2008) Social stress, therapeutics and drug abuse: Preclinical models of escalated and depressed intake. Pharmacol Ther 120:102-128
32. Millan MA, Jacobowitz DM, Hauger RL, Catt KJ, Aguilera G (1986) Distribution of corticotropin-releasing factor receptors in primate brain. Proc Natl Acad Sci USA 83:1921-1925 (Pubitemid 16018675)
33. Moghaddam B (2002) Stress activation of glutamate neurotransmission in the prefrontal cortex: Implications for dopamineassociated psychiatric disorders. Biol Psychiatry 51:775-787 (Pubitemid 34451064)
34. Müller MB, Wurst W (2004) Getting closer to affective disorders: The role of CRH receptor systems. Trends Mol Med 10:409-415 (Pubitemid 39061143)
35. Nikulina EM, Covington HE III, Ganschow L, Hammer RP Jr, Miczek KA (2004) Long-term behavioral and neuronal crosssensitization to amphetamine induced by repeated brief social defeat stress: Fos in the ventral tegmental area and amygdala. Neuroscience 123:857-865 (Pubitemid 38130096)
36. Paxinos G, Watson C (1997) The rat brain in stereotaxic coordinates, 3rd edn. Academic, San Diego
37. Remie R, van Dongen JJ, Rensema JW (1990) Permanent cannulation of the jugular vein (acc. to Steffens). In: Van Dongen JJ (ed) Manual of microsurgery on the laboratory rat. Elsevier, Amsterdam, pp 159-169
38. Reyes BA, Valentino RJ, Van Bockstaele EJ (2008) Stress-induced intracellular trafficking of corticotropin-releasing factor receptors in rat locus coeruleus neurons. Endocrinology 149:122-130
39. Richardson NR, Roberts DCS (1996) Progressive ratio schedules in drug self-administration studies in rats: A method to evaluate reinforcing efficacy. J Neurosci Methods 66:1-11 (Pubitemid 26180064)
40. Risbrough VB, Hauger RL, Pelleymounter MA, Geyer MA (2003) Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice. Psychopharmacology (Berl) 170:178-187 (Pubitemid 37421529)
41. Risbrough VB, Hauger RL, Roberts AL, Vale WW, Geyer MA (2004) Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior. J Neurosci 24:6545-6552 (Pubitemid 38971703)
42. Risbrough VB, Geyer MA, Hauger RL, Coste S, Stenzel-Poore M, Wurst W, Holsboer F (2009) CRF1 and CRF2 receptors are required for potentiated startle to contextual but not discrete cues. Neuropsychopharmacology 34:1494-1503
43. Rodaros D, Caruana DA, Amir S, Stewart J (2007) Corticotropinreleasing factor projections from limbic forebrain and paraventricular nucleus of the hypothalamus to the region of the ventral tegmental area. Neuroscience 150:8-13 (Pubitemid 350198699)
44. Sakanaka M, Shibasaki T, Lederis K (1986) Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex. Brain Res 382:213-238 (Pubitemid 16001730)
45. Sauvage M, Steckler T (2001) Detection of corticotropin-releasing hormone receptor 1 immunoreactivity in cholinergic, dopaminergic and noradrenergic neurons of the murine basal forebrain and brainstem nuclei-potential implication for arousal and attention. Neuroscience 104:643-652 (Pubitemid 32607418)
46. Sawchenko PE, Imaki T, Potter E, Kovacs K, Imaki J, Vale W (1993) The functional neuroanatomy of corticotropin-releasing factor. Ciba Found Symp 172:5-21
47. Schulz DW, Mansbach RS, Sprouse J, Braselton JP, Collins J, Corman M, Dunaiskis A, Faraci S, Schmidt AW, Seeger T, Seymour P, Tingley FD III, Winston EN, Chen YL, Heym J (1996) CP-154,526: A potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proc Natl Acad Sci USA 93:10477-10482 (Pubitemid 26314648)
48. Shaham Y, Funk D, Erb S, Brown TJ, Walker C, Stewart J (1997) Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J Neurosci 17:0-4
49. Shaham Y, Erb S, Leung S, Buczek Y, Stewart J (1998) CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine-and heroin-trained rats. Psychopharmacology (Berl) 137:184-190 (Pubitemid 28227336)
50. Sinha R (2009) Stress and addiction: A dynamic interplay of genes, environment, and drug intake. Biol Psychiatry 66:100-101
51. Sinha R, Garcia M, Paliwal P, Kreek MJ, Rounsaville BJ (2006) Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Arch Gen Psychiatry 63:324-331 (Pubitemid 43345357)
52. Specio SE, Wee S, O'Dell LE, Boutrel B, Zorrilla EP, Koob GF (2008) CRF(1) receptor antagonists attenuate escalated cocaine self-administration in rats. Psychopharmacology (Berl) 196:473-482 (Pubitemid 351191180)
53. Substance Abuse and Mental Health Services Administration (2010) Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of national findings. US Department of Health and Human Services, Rockville
54. Swanson LW, Sawchenko PE, Rivier J, Vale WW (1983) Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: An immunohistochemical study. Neuroendocrinology 36:165-186 (Pubitemid 13138041)
55. Tagliaferro P, Morales M (2008) Synapses between corticotropinreleasing factor-containing axon terminals and dopaminergicneurons in the ventral tegmental area are predominantly glutamatergic. J Comp Neurol 506:616-626
56. Tidey JW, Miczek KA (1996) Social defeat stress selectively alters mesocorticolimbic dopamine release: An in vivo microdialysis study. Brain Res 721:140-149 (Pubitemid 26179847)
57. Tornatzky W, Miczek KA (1995) Alcohol, anxiolytics and social stress in rats. Psychopharmacology (Berl) 121:135-144
58. Ungless MA, Singh V, Crowder TL, Yaka R, Ron D, Bonci A (2003) Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons. Neuron 39:401-407 (Pubitemid 36937043)
59. Valentino RJ, Van BE (2008) Convergent regulation of locus coeruleus activity as an adaptive response to stress. Eur J Pharmacol 583:194-203
60. Van Pett K, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C, Prins GS, Perrin M, Vale W, Sawchenko PE (2000) Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428:191-212
61. Wanat MJ, Hopf FW, Stuber GD, Phillips PE, Bonci A (2008) Corticotropin-releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase Cdependent enhancement of Ih. J Physiol 586:2157-2170 (Pubitemid 351524569)
62. Wang HL, Morales M (2008) Corticotropin-releasing factor binding protein within the ventral tegmental area is expressed in a subset of dopaminergic neurons. J Comp Neurol 509: 302-318
63. Wang B, Shaham Y, Zitzman D, Azari S, Wise RA, You ZB (2005) Cocaine experience establishes control of midbrain glutamate and dopamine by corticotropin-releasing factor: A role in stress-induced relapse to drug seeking. J Neurosci 25:5389-5396 (Pubitemid 40770919)
64. Wang B, You ZB, Rice KC, Wise RA (2007) Stress-induced relapse to cocaine seeking: Roles for the CRF2 receptor and CRF-binding protein in the ventral tegmental area of the rat. Psychopharmacology (Berl) 193:283-294 (Pubitemid 47025028)
65. Wang B, You ZB, Wise RA (2009) Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: Independence from the local corticotropin-releasing factor network. Biol Psychiatry 65:857-862
66. Wolf ME, Xue CJ, White FJ, Dahlin SL (1994) MK-801 does not prevent acute stimulatory effects of amphetamine or cocaine on locomotor activity or extracellular dopamine levels in rat nucleus accumbens. Brain Res 666:223-231 (Pubitemid 24369035)
67. Yap JJ, Covington HE III, Gale MC, Datta R, Miczek KA (2005) Behavioral sensitization due to social defeat stress in mice: Antagonism at mGluR5 and NMDA receptors. Psychopharmacology (Berl) 179:230-239 (Pubitemid 40576710)
68. Zislis G, Desai TV, Prado M, Shah HP, Bruijnzeel AW (2007) Effects of the CRF receptor antagonist D-Phe CRF(12-41) and the alpha2-adrenergic receptor agonist clonidine on stress-induced reinstatement of nicotine-seeking behavior in rats. Neuropharmacology 53:958-966 (Pubitemid 350137393)